Estimated prevalence of injection-site sarcomas in cats during 1992

Michael J. Coyne From the Animal Health Group, Pfizer Inc, New York, NY 10017-5755 (Coyne), and the Animal Health Group, Pfizer Inc, North America Region, Exton, PA 19341 (Reeves, Rosen).

Search for other papers by Michael J. Coyne in
Current site
Google Scholar
PubMed
Close
 VMD, PhD
,
Nancy C. Postorino Reeves From the Animal Health Group, Pfizer Inc, New York, NY 10017-5755 (Coyne), and the Animal Health Group, Pfizer Inc, North America Region, Exton, PA 19341 (Reeves, Rosen).

Search for other papers by Nancy C. Postorino Reeves in
Current site
Google Scholar
PubMed
Close
 DVM, MS
, and
David K. Rosen From the Animal Health Group, Pfizer Inc, New York, NY 10017-5755 (Coyne), and the Animal Health Group, Pfizer Inc, North America Region, Exton, PA 19341 (Reeves, Rosen).

Search for other papers by David K. Rosen in
Current site
Google Scholar
PubMed
Close
 DVM

Objective

To obtain an estimate of the yearly prevalence of injection-site sarcomas in cats.

Design

Mail survey of members of the American Association of Feline Practitioners.

Procedure

A questionnaire was sent to 1,112 veterinarians.

Results

235 responses were sufficiently complete for inclusion in the study. Overall, responding veterinarians reported 744,993 cat visits in 1992, representing 434,638 individual cats (1.7 visits/cat). The estimated overall prevalence of injection-site sarcomas during 1992 was 0.00021 cases/cat visit (2.1 cases/10,000 cat visits) or 0.00036 cases/cat (3.6 cases/10,000 cats).

Clinical Implications

Results suggest that injection-site sarcomas were rare during 1992.

Objective

To obtain an estimate of the yearly prevalence of injection-site sarcomas in cats.

Design

Mail survey of members of the American Association of Feline Practitioners.

Procedure

A questionnaire was sent to 1,112 veterinarians.

Results

235 responses were sufficiently complete for inclusion in the study. Overall, responding veterinarians reported 744,993 cat visits in 1992, representing 434,638 individual cats (1.7 visits/cat). The estimated overall prevalence of injection-site sarcomas during 1992 was 0.00021 cases/cat visit (2.1 cases/10,000 cat visits) or 0.00036 cases/cat (3.6 cases/10,000 cats).

Clinical Implications

Results suggest that injection-site sarcomas were rare during 1992.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 935 916 163
PDF Downloads 94 74 8
Advertisement